Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Exelixis stock dropped out of a buy zone Friday after the FDA delayed the potential approval of its new colon cancer treatment.
The post Exelixis, An IBD 50 Stock, Pulls A Bearish Move With Surprise Cancer Delay appeared first on Investor’s Business Daily.
